Home LiteratureArticle Details
PMID: 83018 Published · ppublish English Journal Article

The operation of immunological networks in Graves' disease.

Tissue antigens ·Vol. 12 ·No. 3 ·1978-09-00 ·Pages 205-11

Farid NR, Newton RM, Noel EP, Barnard JM, Marshall WH

Abstract

Association between Graves' disease and HLA--B8 has been previously documented, as have been associations between 1 gG heavy chain allotype markers (Gm). We found a significant increase in the phenotype fnb/fb (ie. positivity for fb) in patients with Graves' disease compared to controls, raising the possibility of allotypic restriction of thyroid stimulating antibodies thought to be causally related to the disease. The influence of fb on the susceptibility to Graves' disease was found to be independent of HLA--B8 status suggesting that the immunological network operated by the Histocompatibility-linked genes is independent of that centered around IgG allotypes. It is postulated that, whereas the former genes determine the level of helper T lymphocyte function in the production of thyroid stimulating antibodies in Graves' disease, a person who also happens to carry the Gm marker fb would be assured of the production of IgG antibodies with thyroid stimulatory activity.

MeSH Terms
Adult Epitopes Graves Disease/genetics,immunology HLA Antigens Haploidy Humans Immunoglobulin G/genetics Phenotype
Chemicals
Epitopes HLA Antigens Immunoglobulin G
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Farid N R
Newton R M
Noel E P
Barnard J M
Marshall W H
Article Info
Journal
Tissue antigens
Abbr.
Tissue Antigens
ISSN
0001-2815
Published
1978-09-00
Pages
205-11
Language
English
Region
England
NLM ID
0331072
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]